Skip to content

SMETS PHARMA

Active
Private limited companyfounded 1968active for 58 yearsAntwerpsesteenweg 36-38, 2500 Lier, BelgiumKBO/BCE: BE 0404.059.834

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
07-07
NBB filing Annual accounts 2025 filedNBB
abbreviated format · 24 days before the deadline
2025
31-12
Financial Highest result from 2018 to 2025net €40,740 ▲8.8%
The net result of €40,740 is the highest of those years.
27-06
NBB filing Annual accounts 2024 filedPDF
abbreviated format · 34 days before the deadline
2024
31-12
Financial Equity above €200,000equity €201,739 ▲22.1%
After 3 profitable years in a row, equity reaches €201,739.
19-04
NBB filing Annual accounts 2023 filedPDF
abbreviated format · 103 days before the deadline
2023
29-08
Gazette deed Merger: SMETS PHARMA takes over ISCONI
Resignations: SMETS Isaline Antonia Andrea Martha (director) and ISCONI (director) · Permanent representative: SMETS Isaline Antonia Andrea Martha · Appointment: SMETS Isaline Antonia Andrea Martha (director)19 points ▸
  • Capital
  • Other provision, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • General meeting, 24-07-2023
  • Merger, “fusie door overneming, ISCONI” (deed in Dutch)
  • Other provision, “vennoten, verzaking aan fusieverslagen en cijfers” (deed in Dutch)
  • Auditor report, EUR, “Norm inzake opdracht bedrijfsrevisor inbreng in natura en quasi-inbreng IBR” (deed in Dutch)
  • Other provision, 18-07-2023
  • Merger, “fusie door overneming”, 25000.0 (deed in Dutch)
  • Share issue, “inbreng verhoging, enige vennoot overgenomen vennootschap” (deed in Dutch)
  • Power of attorney
  • Share cancellation, 19296, “vaststelling en vernietiging eigen aandelen” (deed in Dutch)
  • Other provision, “uitbreiding van het voorwerp en verslaggeving overnemende vennootschap” (deed in Dutch)
  • The act holds 7 more points.

Open the act in the Belgian Official Gazette

24-04
NBB filing Annual accounts 2022 filedPDF
abbreviated format · 98 days before the deadline
29-03
Gazette deed Merger proposal: Smets Pharma takes over ISCONI
Permanent representative: Isaline Smets · Appointments: Isaline Smets (director) and ISCONI (director) · Incorporation29 points ▸
  • Board meeting, 14-03-2023
  • Merger, “fusie door overneming, volledig tegen uitreiking van aandelen” (deed in Dutch)
  • Permanent representative, Isaline Smets
  • Director in office, Isaline Smets (director), mentioned 2 times in the deed
  • Other provision, “ANTWERPEN afdeling MECHELEN, neerlegging en bekendmaking fusievoorstel” (deed in Dutch)
  • Incorporation, 04-10-2005
  • Other provision, “statutenwijziging ISCONI, sedertdien niet meer gewijzigd” (deed in Dutch)
  • Capital, €25,000
  • Director appointment, Isaline Smets (director)
  • Incorporation, 01-02-1960
  • Amendment of the articles
  • Registered office clause, “BE404.059.834, 2500 LIER,Antwerpsesteenweg 36-38” (deed in Dutch)
  • The act holds 17 more points.

Open the act in the Belgian Official Gazette

2022
31-12
Financial Back to profitnet €5,426
The net result is €5,426, after one loss-making year.
20-05
NBB filing Annual accounts 2021 filedPDF
abbreviated format · 72 days before the deadline
18-01
Gazette deed Transfer of 1 share
Change of role: ISCONI, from director and managing director to director · Resignation: SMETS Constant Juliaan (director) · Permanent representative: SMETS Isaline Antonia Andrea Martha23 points ▸
  • General meeting, 14-12-2021
  • Amendment of the articles, mentioned 2 times in the deed
  • Capital conversion, “inbreng in besloten vennootschap” (deed in Dutch)
  • Other provision, “voorlezing bijzonder verslag en staat, bijzonder verslag bestuurders” (deed in Dutch)
  • Net-asset statement, 30-09-2021
  • Auditor report, 259938.48, EUR
  • Other provision, “kennisname en verzaking inzagetermijn, alle comparanten” (deed in Dutch)
  • Legal-form conversion, “besloten vennootschap” (deed in Dutch)
  • Accounting effect, 30-09-2021
  • Other provision, “ongewijzigde elementen en akkoord, eenparigheid van stemmen” (deed in Dutch)
  • Capital
  • Director resignation, ISCONI (director and managing director)
  • The act holds 11 more points.

Open the act in the Belgian Official Gazette

2021
31-12
Financial Weakest financial yearnet -€4,030
The net result drops to -€4,030, the lowest from 2018 to 2025. It recovers the following year.
Show earlier events
05-08
NBB filing Annual accounts 2020 filedPDF
abbreviated format · 5 days late
2020
14-05
NBB filing Annual accounts 2019 filedPDF
abbreviated format · 78 days before the deadline
2019
27-06
NBB filing Annual accounts 2018 filedPDF
abbreviated format · 34 days before the deadline
2018
05-06
NBB filing Annual accounts 2017 filedPDF
abbreviated format · 56 days before the deadline
2017
29-08
NBB filing Annual accounts 2016 filedPDF
abbreviated format · 29 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

SMETS PHARMA was incorporated on 1 January 1968.1 In 2023 the company absorbed ISCONI by merger.2 Total assets rose from €396,501 in 2023 to €452,862 in 2025 and headcount from 2.3 to 2.2 full-time equivalents.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 29-08-2023
  3. 3National Bank, annual accounts 2023 and 2025

Next steps